![]() InhaleRx InhaleRx (formerly known as Lifespot Health) is a company that provides inhaled medication systems. | ![]() SPR Therapeutics SPR Therapeutics is a medical device company that develops peripheral nerve stimulation (PNS) technology. | ![]() ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers. | ![]() ABK Biomedical ABK Biomedical is a medical device company dedicated to the research, development and commercialization of innovative embolic therapies. | |
Founding Date | Founding Date 2016 | Founding Date 2010 | Founding Date 2006 | Founding Date 2012 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Melbourne, AU HQ | Locations Cleveland, US HQ | Locations Calabasas, US HQ | Locations Halifax, CA HQ Ladera Ranch, US |
Employees | Employees N/A | Employees 3266% increase | Employees 357% decrease | Employees 403% increase |
Valuation ($) | Valuation ($) 4.2 m | Valuation ($) N/A | Valuation ($) 15.9 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($1.6m) (FY, 2025) | Net income N/A | Net income ($14.3m) (FY, 2017) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 25m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 30m (about 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 33.7m | Total funding raised $ 32.5m | Total funding raised $ 37.4m |

SPR Therapeutics is a medical device company that develops peripheral nerve stimulation (PNS) technology.
View company
ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.
View company
ABK Biomedical is a medical device company dedicated to the research, development and commercialization of innovative embolic therapies.
View company